(19)

(11)

EP 4 798 158 A1

(12)

(43) Date of publication: 02.09.2026 Bulletin 2026/36 (21) Application number: 24881633.2 (22) Date of filing: 23.10.2024

(51) International Patent Classification (IPC):  A61K 8/64(2006.01) A61P 17/02(2006.01) C07K 7/08(2006.01) A61K 38/00(2006.01) (52) Cooperative Patent Classification (CPC): C07K 7/06; C07K 5/1019; C07K 5/0815; A61K 38/00; A61K 8/64; A61P 17/00; C07K 14/43504; A61K 9/0014; A61K 9/006; A61K 47/06; A61K 47/542; A61K 47/55 (86) International application number: PCT/CN2024/126655 (87) International publication number: WO 2025/087269 (01.05.2025 Gazette 2025/18)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 23.10.2023 WO PCT/CN2023/126032 (71) Applicant: EnliTISA (Shanghai) Pharmaceutical Co., Ltd. Shanghai 201318 (CN)	(72) Inventors: HAEGGSTRÖM, Jesper 171 77 Stockholm (SE) GU, Ming Shanghai 201318 (CN) KANG, Ruijuan Shanghai 201318 (CN) SONG, Maoqian Shanghai 201318 (CN) (74) Representative: Potter Clarkson  Chapel Quarter Mount Street Nottingham NG1 6HQ Nottingham NG1 6HQ (GB)